stockrowKiniksa Pharmaceuticals International, plc
KNSA Healthcare Drug Manufacturers Specialty & Generic
Kiniksa Pharmaceuticals International, plc’s revenue for fiscal 2025 (year ended December 2025) was $677.6 million, up 60.1% from fiscal 2024.
- Revenue
- +58.1%
- EPS
- +142.2%
- Free cash flow
- +43.5%
Quarter to September 2026, against a year earlier
Follow KNSA
Alert me
Kiniksa Pharmaceuticals International, plc (KNSA) Return on assets
Kiniksa Pharmaceuticals International, plc's return on assets over the twelve months to 30 September 2026 was 12.9%, up 4.1 percentage points from fiscal 2025 (8.78%). Over the past ten years it has ranged from −124.8% (fiscal 2017) to 53.0% (fiscal 2022); the current reading is higher than 90% of that period. That is above the Drug Manufacturers Specialty & Generic industry median of −1.67% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | 8.78% | 16.58 |
| FY2024 | −7.80% | (10.66) |
| FY2023 | 2.86% | (50.10) |
| FY2022 | 53.0% | 107.20 |
| FY2021 | −54.2% | (0.80) |
| FY2020 | −53.4% | 2.72 |
| FY2019 | −56.2% | (0.28) |
| FY2018 | −55.9% | 68.92 |
| FY2017 | −124.8% | (78.68) |
| FY2016 | −46.1% | — |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| LQDA Liquidia Corporation compare | 35.6% |
| SUPN Indivior Pharmaceuticals Inc. compare | 32.8% |
| KNSA Kiniksa Pharmaceuticals International, plc | 12.9% |
| LNTH Lantheus Holdings, Inc. compare | 11.4% |
| RDY Dr. Reddy's Laboratories Ltd compare | 4.44% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 3.01% |
| ALKS Alkermes plc compare | −0.01% |
| ELAN Elanco Animal Health Incorporated compare | −1.46% |
| HIMS Hims & Hers Health, Inc. compare | −5.16% |
| Drug Manufacturers Specialty & Generic industry median | −1.67% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on KNSA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement